CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 585 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Bioservices gave up 665 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-K Report Annual Report
- 4 Shares withheld for taxes SVP, Bioservices gave up 346 shares (to pay taxes)
- 8-K Event Material agreement · Results of operations · New debt or obligation · Regulation FD disclosure
- 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 381 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Products Business gave up 587 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 9,721 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Ext Aff, GC, Corp Sec gave up 4,806 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes SVP, Products Business gave up 105 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Ext Aff, GC, Corp Sec gave up 229 shares (to pay taxes)
Page 13 of 87 · 1,733 filings